1)Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002; 91: 988-98
|
|
|
2)Ahn J, Kim J. Mechanisms and consequences of inflammatory signaling in the myocardium. Curr hypertens Rep. 2012; 14: 510-6
|
|
|
3)Marchant DJ, Boyd JH, Lin DC, et al. Inflam-mation in myocardial diseases. Circ Res. 2012; 110: 126-44
|
|
|
4)Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990; 323: 236-41
|
|
|
5)Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995; 92: 1479-86
|
|
|
6)Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996; 28: 964-71
|
|
|
7)Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001; 103: 2055-9
|
|
|
8)Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 1997; 81: 627-35
|
|
|
9)Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004; 109: 1594-602
|
|
|
10)Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003; 107: 3133-40
|
|
|
11)Baetz D, Regula KM, Ens K, et al. Nuclear factor-kappaB-mediated cell survival involves trans-criptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation. 2005; 112: 3777-85
|
|
|
12)Hikoso S, Yamaguchi O, Nakano Y, et al. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res. 2009; 105: 70-9
|
|
|
13)Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004; 432: 1032-6
|
|
|
14)Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006; 441: 885-9
|
|
|
15)Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006; 441: 880-4
|
|
|
16)Shimomura H, Terasaki F, Hayashi T, et al. Autophagic degeneration as a possible mecha-nism of myocardial cell death in dilated cardio-myopathy. Jpn Circ J. 2001; 65: 965-8
|
|
|
17)Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007; 13: 619-24
|
|
|
18)Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemo-dynamic stress. J Clin Invest. 2007; 117: 1782-93
|
|
|
19)Taneike M, Yamaguchi O, Nakai A, et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010; 6: 600-6
|
|
|
20)Okamoto K, Kondo-Okamoto N, Ohsumi Y. Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev Cell. 2009; 17: 87-97
|
|
|
21)Billia F, Hauck L, Konecny F, et al. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci U S A. 2011; 108: 9572-7
|
|
|
22)Huang C, Andres AM, Ratliff EP, et al. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One. 2011; 6: e20975
|
|
|
23)Oka T, Hikoso S, Yamaguchi O, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012; 485: 251-5
|
|
|